These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32163717)

  • 1. The Fit fOR The Aged (FORTA) project and its clinical implications.
    Pazan F; Wehling M
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):275-277. PubMed ID: 32163717
    [No Abstract]   [Full Text] [Related]  

  • 2. [The FORTA (Fit fOR The Aged) List].
    Pazan F; Wehling M
    Inn Med (Heidelb); 2024 Jan; 65(1):3-8. PubMed ID: 38063911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and deprescribing: just ask the patient.
    Cave JA
    Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing medication burden and polypharmacy: finding the perfect measure.
    Gnjidic D; Tinetti M; Allore HG
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):345-347. PubMed ID: 28271722
    [No Abstract]   [Full Text] [Related]  

  • 5. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.
    Michalek C; Wehling M; Schlitzer J; Frohnhofen H
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1261-7. PubMed ID: 25128076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.
    Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Mendez-Valera P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):425-37. PubMed ID: 25703585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People.
    Rabenberg A; Schulte T; Hildebrandt H; Wehling M
    Drugs Aging; 2019 Oct; 36(10):969-978. PubMed ID: 31435913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing: A simple method for reducing polypharmacy.
    McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
    J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing issues in elderly individuals living with HIV.
    Marzolini C; Livio F
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
    [No Abstract]   [Full Text] [Related]  

  • 13. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
    Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Good prescribing practice in the elderly].
    Wickop B; Langebrake C
    Ther Umsch; 2014 Jun; 71(6):366-73. PubMed ID: 24867351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical consequences of polypharmacy in elderly.
    Maher RL; Hanlon J; Hajjar ER
    Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
    Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
    Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic challenges and emerging approaches to medication therapy in older adults.
    Alagiakrishnan K; Mah D; Padwal R
    Discov Med; 2018 Oct; 26(143):137-146. PubMed ID: 30586537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
    Wehling M; Burkhardt H; Kuhn-Thiel A; Pazan F; Throm C; Weiss C; Frohnhofen H
    Age Ageing; 2016 Mar; 45(2):262-7. PubMed ID: 26786346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.